Last reviewed · How we verify
NCT03808727
Massed Cognitive Processing Therapy for Combat-related PTSD
NA trial testing Cognitive Processing Therapy in PTSD, Post Traumatic Stress Disorder in 140 participants. Completed in 31 December 2022.
13 May 2022
Quick facts
| Lead sponsor | VA Boston Healthcare System |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 140 |
| Start date | 5 March 2019 |
| Primary completion | 13 May 2022 |
| Estimated completion | 31 December 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cognitive Processing Therapy
Conditions studied
- PTSD, Post Traumatic Stress Disorder — all drugs for PTSD, Post Traumatic Stress Disorder →
Sponsor
VA Boston Healthcare System
Who can join
18 and older, any sex, with PTSD, Post Traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine if cognitive processing therapy (CPT) delivered in a massed format (MCPT) is as effective as standard delivery of CPT. MCPT will be delivered in an intensive outpatient setting (12 sessions in 5 days) composed of both group and individual sessions. Standard delivery of CPT consists of 12 sessions over 6 weeks and involves only individual sessions. Assessment of PTSD and related symptoms will be conducted at pre-treatment and 1 month and 4 months following treatment in both conditions. Additionally, in order to compare the treatment groups at the same point in actual time, each group will be assessed at the one month posttreatment time point for the other condition.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03808727
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive Processing Therapy
Trials testing the same drug.
- NCT06570213 — Evaluating The Efficacy Of Combined Cognitive Processing Therapy and Stellate Ganglion Blocks for PTSD · EARLY_PHASE1 · not yet recruiting
- NCT07238192 — Augmenting Massed Cognitive Processing Therapy (CPT) to Prevent Suicide Risk Among Patients With PTSD · NA · recruiting
- NCT06733376 — Evaluating Evidenced Based Options for PTSD Treatment · NA · recruiting
- NCT06957067 — Reducing Dropout and Improving Outcomes From PTSD Therapy: When to Switch Therapies or Stay the Course · NA · recruiting
- NCT06000475 — Enhancing Memory in CPT for PTSD · NA · recruiting
Other recruiting trials for PTSD, Post Traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06394284 — Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural · Phase 3 · recruiting
Other VA Boston Healthcare System trials
Trials by the same sponsor.
- NCT06389981 — Co-Design and Pilot Testing of Peer-led Community Outreach to Improve Equity, Veteran-Centeredness and Uptake of Lung Ca · NA · completed
- NCT06792877 — Mindfulness for Cognition in Early-stage Alzheimer's Disease · NA · recruiting
- NCT05663151 — Mechanisms Underlying the Efficacy of Prolonged Exposure · NA · recruiting
- NCT04723745 — Translational Research Center for TBI and Stress Disorders: Virtual Assessment of Deployment Trauma and Rehabilitation · unknown
- NCT04154462 — Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03808727 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by VA Boston Healthcare System
- Last refreshed: 6 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03808727.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing